Congenital Dysfibrinogenaemia: A Family Case Report
Article Sidebar
Main Article Content
Abstract
Congenital fibrinogen qualitative disorders, including dysfibrinogenemia and hypo-dysfibrinogenaemia, are highly heterogeneous, both in clinical manifestation and for the mutational molecular spectrum driving these disorders. Correlations between phenotype and genotype remain poorly defined. Considerable work lies ahead in order to achieve diagnostic and prognostic precision and subsequently provide targeted management for this rare disease. Here we report the laboratory test, the clinical and molecular characterisation of a family with dysfibrinogenemia.
Article Details
Copyright (c) 2024 García-Donas G, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015 26;125(13):2052-61. Available from: https://doi.org/10.1182/blood-2014-08-532820
Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al. BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014 ;167(3):304-26. Available from: https://doi.org/10.1111/bjh.13058
Casini A, Undas A, Palla R, Thachil J, de Moerloose P. Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1887–90. Available from: https://doi.org/10.1111/jth.14216
Cunningham MT, Brandt JT, Laposata M, Olson JD. Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med. 2002;126(4):499-505. Available from: https://doi.org/10.5858/2002-126-0499-ldod
Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT-derived method in patients with dysfibrinogenemia. Thromb Res. 2010;126(6):e428–33. Available from: https://doi.org/10.1016/j.thromres.2010.09.004
Galanakis DK. Afibrinogenemias and dysfibrinogenemias. In: Marder V, White GC, Aird WC, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins. 2012;693-708.
Cunningham F, Allen JE, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, et al. Ensembl 2022. Nucleic Acids Res. 2022;50(D1):D988–95. Available from: https://doi.org/10.1093/nar/gkab1049
Shapiro SE, Phillips E, Manning RA, Morse CV, Murden SL, Laffan MA, Mumford AD. Clinical phenotype, laboratory features, and genotype of 35 patients with heritable dysfibrinogenaemia. Br J Haematol. 2013;160(2):220-7. Available from: https://doi.org/10.1111/bjh.12085
Ebert RF. Index of Variant Human Fibrinogens. Boca Raton, Ann Arbor, Boston: CRC Press; 1994. Available from: https://www.routledge.com/Index-of-Variant-Human-Fibrinogens/Ebert/p/book/9780849389986?srsltid=AfmBOopqoE9HdkcaIiZ7BrhTrATa5hagIOZ2AJ3ShfalPEizfz5JcfOY
Smith N, Bornikova L, Noetzli L, Guglielmone H, Minoldo S, Backos DS, et al. Identification and characterization of novel mutations implicated in congenital fibrinogen disorders. Res Pract Thromb Haemost. 2018;2(4):800-811. Available from: https://doi.org/10.1002/rth2.12127
Casini A, Neerman-Arbez M, Ariëns RA, de Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost. 2015;13(6):909-19. Available from: https://doi.org/10.1111/jth.12916
Neerman-Arbez M, de Moerloose P, Bridel C, Honsberger A, Schönbörner A, Rossier C, et al. Mutations in the fibrinogen α gene account for the majority of cases of congenital afibrinogenemia. Blood. 2000;96(1):149-52. PMID: 10891444. Available from: https://pubmed.ncbi.nlm.nih.gov/10891444/
Hanss M, Biot F. A database for human fibrinogen variants. Ann NY Acad Sci. 2001;936:89–90. Available from: https://doi.org/10.1111/j.1749-6632.2001.tb03495.x
Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, et al. Natural history of patients with congenital dysfibrinogenemia. Blood. 2015;125(3):553–61. Available from: https://doi.org/10.1182/blood-2014-06-582866
Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost. 1995;73(1):151-61. PMID: 7740487. Available from: https://pubmed.ncbi.nlm.nih.gov/7740487/
Asselta R, Platè M, Robusto M, Borhany M, Guella I, Soldà G, et al. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency. Thromb Haemost. 2015;113(3):567-76. Available from: https://doi.org/10.1160/th14-07-0629
Bor MV, Feddersen S, Pedersen IS, Sidelmann JJ, Kristensen SR. Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding. Semin Thromb Hemost. 2022;48(2):161-173. Available from: https://doi.org/10.1055/s-0041-1730358
Ramanan R, McFadyen JD, Perkins AC, Tran HA. Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools. Br J Haematol. 2023;203(3):355-368. Available from: https://doi.org/10.1111/bjh.19039
Peyvandi F, Kaufman RJ, Seligsohn U, Salomon O, Bolton-Maggs PH, et al. Rare bleeding disorders. Haemophilia. 2006;12 Suppl 3:137-42. Available from: https://doi.org/10.1111/j.1365-2516.2006.01271.x
Duric N, Szakmany T. The role of rotational thromboelastometry in understanding the coagulation problems in COVID-19 associated critical illness. Anaesthesiol Intensive Ther. 2021;53(4):336-342. Available from: https://doi.org/10.5114/ait.2021.109401
Reardon B, Pasalic L, Favaloro EJ. The Role of Viscoelastic Testing in Assessing Hemostasis: A Challenge to Standard Laboratory Assays? J Clin Med. 2024;13(12):3612. Available from: https://doi.org/10.3390/jcm13123612
Williams M, Green K. Role of mass spectrometry in the diagnosis of congenital fibrinogen defects. Blood Coagulation & Fibrinolysis. 2021;32(4):333-338.
Tian D, Liang J, Gao H, Xu X, Nie W, Yin M, et al. Clinical phenotype and laboratory characteristics of 93 patients with congenital fibrinogen disorders from unrelated 36 families. Res Pract Thromb Haemost. 2024;8:e102445. Available from: https://doi.org/10.1016/j.rpth.2024.102445
Castaman G, Kessler CM. Genotype-phenotype correlation in congenital dysfibrinogenemia: New insights. Blood Adv. 2022;6(16):4978-4984.
Paraboschi EM, Duga S, Asselta R. Fibrinogen as a pleiotropic protein causing human diseases: The mutational burden of Aα, Bβ, and γ chains. Int J Mol Sci. 2017;18(12):2711. Available from: https://doi.org/10.3390/ijms18122711
Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J, et al. Clinical features and molecular basis of 102 Chinese patients with congenital fibrinogen disorders. Blood Cells Mol Dis. 2015;55(4):308–15. Available from: https://doi.org/10.1016/j.bcmd.2015.06.002
Marchi R, Vilar R, Durual S, Goodyer M, Gay V, Neerman-Arbez M, et al. Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations. Thromb Res. 2021;197:56–64. Available from: https://doi.org/10.1016/j.thromres.2020.11.003
Ceznerova E, Kaufmanova J, Sovova Ž, Štikarova J, Loužil J, Kotlin R, et al. Structural and functional characterization of four novel fibrinogen mutations in FGB causing congenital fibrinogen disorder. Int J Mol Sci. 2022;23(2):721. Available from: https://doi.org/10.3390/ijms23020721
Moret A, Zuniga A, Ibanez M, Cid AR, Haya S, Ferrando F, et al. Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen. Thromb Res. 2019;180:115–7. Available from: https://doi.org/10.1016/j.thromres.2019.06.015
Liu X, Wang X, Zhang J. Advances in the genetic diagnosis of congenital dysfibrinogenemia: the role of next-generation sequencing. J Thromb Haemost. 2023;21(7):1355-1363.
Gindele R, Kerenyi A, Kallai J, Pfliegler G, Schlammadinger A, Szegedi I, et al. Resolving differential diagnostic problems in von Willebrand disease, in fibrinogen disorders, in Prekallikrein deficiency and in hereditary hemorrhagic telangiectasia by next-generation sequencing. Life. 2021;11(3):202. Available from: https://doi.org/10.3390/life11030202
Neerman-Arbez M, de Moerloose P. Williams Hematology. New York: McGraw-Hill; 2010.
Weisel JW, Litvinov RI. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013;121(10):1712-9. Available from: https://doi.org/10.1182/blood-2012-09-306639
Richard M, Celeny D, Neerman-Arbez M. Mutations accounting for congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2022;48(8):889–903. Available from: https://doi.org/10.1055/s-0041-1742170
Meh DA, Mosesson MW, Siebenlist KR, Simpson-Haidaris PJ, Brennan SO, DiOrio JP, et al. Fibrinogen Naples I (B beta A68T) nonsubstrate thrombin-binding capacities. Thromb Res. 2001;103(1):63–73. Available from: https://epublications.marquette.edu/biomedsci_fac/47/
Huffman JE, de Vries PS, Morrison AC, Sabater-Lleal M, Kacprowski T, Auer PL, et al. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood. 2015;126(11):e19–e29. Available from: https://doi.org/10.1182/blood-2015-02-624551
de Vries PS, Chasman DI, Sabater-Lleal M, Chen MH, Huffman JE, Steri M, et al. A meta-analysis of 120,246 individuals identifies 18 new loci for fibrinogen concentration. Hum Mol Genet. 2016;25(2):358–70. Available from: https://doi.org/10.1093/hmg/ddv454
Pankratz N, Wei P, Brody JA, Chen MH, de Vries PS, Huffman JE, et al. Whole-exome sequencing of 14,389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors. Hum Mol Genet. 2022;31(18):3120–32. Available from: https://doi.org/10.1093/hmg/ddac100
Bornikova L, Peyvandi F, Allen G, Bernstein J, Manco-Johnson MJ. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost. 2011;9(9):1687-704. Available from: https://doi.org/10.1111/j.1538-7836.2011.04424.x
Casini A, de Moerloose P. How I treat dysfibrinogenemia. Blood. 2021;138(21):2021–2030. Available from: https://doi.org/10.1182/blood.2020010116
Li Y, Ding B, Wang X, Ding Q. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review. Thromb Res. 2022;217:36-47. Available from: https://doi.org/10.1016/j.thromres.2022.07.005
Casini A, de Moerloose P. Can the phenotype of inherited fibrinogen disorders be predicted? Haemophilia. 2016;22(5):667-75. Available from: https://doi.org/10.1111/hae.12967
Casini A. From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders. Hamostaseologie. 2020;40(4):460-466. Available from: https://doi.org/10.1055/a-1182-3510